Schlafen 11 (SLFN11), a putative predictive biomarker of platinum/PARPi response, is frequently detected on circulating tumor cells (CTCs) in advanced prostate cancer Meeting Abstract
| Authors: | Scher, H. I.; Fernandez, L.; Cunningham, K.; Elphick, N.; Barnett, E.; Lee, J.; Gilbertson, C.; Carbone, E.; Bourdon, D.; Blankfard, M.; Wang, E.; Jones, J. T.; Tubbs, A.; Anderson, A.; Schonhoft, J. D.; Wenstrup, R. |
| Abstract Title: | Schlafen 11 (SLFN11), a putative predictive biomarker of platinum/PARPi response, is frequently detected on circulating tumor cells (CTCs) in advanced prostate cancer |
| Meeting Title: | 2021 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 39 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2021 Jun 4-8 |
| Meeting Location: | Virtual |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2021-05-20 |
| Language: | English |
| ACCESSION: | WOS:000708120302309 |
| DOI: | 10.1200/JCO.2021.39.15_suppl.e17039 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: e17039 -- Source: Wos |
Altmetric
Citation Impact
Related MSK Work